Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension. (2021)
Attributed to:
MICA: The Newcastle Proximity Laboratory
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(21)00344-2
PubMed Identifier: 34592193
Publication URI: http://europepmc.org/abstract/MED/34592193
Type: Journal Article/Review
Volume: 22
Parent Publication: The Lancet. Oncology
Issue: 10
ISSN: 1470-2045